PAMA laboratory reimbursement cuts delayed through 2024
PAMA Reporting Delayed Again as Permanent Fix Sought Labs received a welcome reprieve from looming Clinical Lab Fee Schedule (CLFS) cuts this month when Protecting Access to Medicare Act (PAMA) reporting and associated test reimbursement reductions were delayed until...
CMS to Withdraw NCCI Edit Impacting Drug Testing
CMS is withdrawing NCCI PTP edits between Column One codes 80305, 80306, and 80307 for presumptive test(s), and Column Two codes G0480 – G0483, and G0659 for definitive test(s), according to an announcement posted on the agency’s website and communications from... Solutions for Sustaining Clinical Pathology Revenue Amidst Challenges
For hospital-based pathology groups, mastering the complex revenue cycle management processes surrounding the capture and billing of Professional Component of Clinical Laboratory (PCCP) services is paramount when the group is not being otherwise compensated through... Cuts for Labs, Pathology again proposed for 2024 Medicare Fee Schedule
The 2024 Medicare Physician Fee Schedule Proposed Rule released July 13 is already generating pushback from lab and pathology advocates, such at the College of American Pathologists (CAP), who contend these services and the physicians who provide them cannot sustain... 
Lighthouse Acquires MJB Lab Consulting, Expanding Medical Leadership Services